Related references
Note: Only part of the references are listed.Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma
Georgina V. Long et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR
Hans Boesmueller et al.
HUMAN PATHOLOGY (2013)
Detection of BRAF p.V600E Mutations in Melanomas Comparison of Four Methods Argues for Sequential Use of Immunohistochemistry and Pyrosequencing
Emeline Colomba et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases
David Capper et al.
ACTA NEUROPATHOLOGICA (2012)
Immunohistochemical Detection of the BRAF V600E-mutated Protein in Papillary Thyroid Carcinoma
Oskar Koperek et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
Felix Sahm et al.
BLOOD (2012)
Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma
M. Bullock et al.
ENDOCRINE-RELATED CANCER (2012)
Detection of BRAF V600E mutations in skin metastases of malignant melanoma by monoclonal antibody VE1
Alexander Skorokhod et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Pediatric Primary Anaplastic Ganglioglioma: A Case Report and Review of the Literature
Silvia Scoccianti et al.
PEDIATRIC NEUROSURGERY (2012)
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
David Capper et al.
ACTA NEUROPATHOLOGICA (2011)
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
Genevieve Schindler et al.
ACTA NEUROPATHOLOGICA (2011)
Genetic Aberrations Leading to MAPK Pathway Activation Mediate Oncogene-Induced Senescence in Sporadic Pilocytic Astrocytomas
Karine Jacob et al.
CLINICAL CANCER RESEARCH (2011)
BRAF Activation Induces Transformation and Then Senescence in Human Neural Stem Cells: A Pilocytic Astrocytoma Model
Eric H. Raabe et al.
CLINICAL CANCER RESEARCH (2011)
Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma
Anja E. Eisenhardt et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma
Georgina V. Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Malignant ganglioglioma: case report and review of literature
Ryan DeMarchi et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults
M. Hasselblatt et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
Dora Dias-Santagata et al.
PLOS ONE (2011)
Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas
Joshua D. Schiffman et al.
CANCER RESEARCH (2010)
Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas
Margaret J. Dougherty et al.
NEURO-ONCOLOGY (2010)
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2009)
Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours
K. Jacob et al.
BRITISH JOURNAL OF CANCER (2009)
Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas
Tim Forshew et al.
JOURNAL OF PATHOLOGY (2009)
Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
Laura E. MacConaill et al.
PLOS ONE (2009)
Comprehensive characterization of genomic aberrations in gangliogliomas by CGH, array-based CGH and interphase FISH
Alexander Hoischen et al.
BRAIN PATHOLOGY (2008)
Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic Astrocytomas
David T. W. Jones et al.
CANCER RESEARCH (2008)
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Stefan Pfister et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Clinical and molecular characteristics of malignant transformation of low-grade glioma in children
Alberto Broniscer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
NRAS and BRAF mutations in melanoma turnours in re ation to clinical characteristics:: a study based on mutation screening by pyrosequencing
Esther Edlundh-Rose et al.
MELANOMA RESEARCH (2006)
BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status
Wei Qi Li et al.
MOLECULAR CANCER (2006)
The Ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer
TL Lo et al.
CANCER RESEARCH (2004)
SPRY2 is an inhibitor of the Ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant
D Tsavachidou et al.
CANCER RESEARCH (2004)
Immunogenicity of constitutively active V599EBRaf
MH Andersen et al.
CANCER RESEARCH (2004)
Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas
CB Knobbe et al.
ACTA NEUROPATHOLOGICA (2004)
Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer
T Furukawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Mutational analysis of TSC1 and TSC2 genes in gangliogliomas
AJ Becker et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2001)
Share Paper
